Literature DB >> 28547808

Cytokine response in crimean-congo hemorrhagic fever virus infection.

Önder Ergönül1, Ceren Şeref2, Şebnem Eren3, Aysel Çelikbaş3, Nurcan Baykam4, Başak Dokuzoğuz3, Mehmet Gönen2,5, Füsun Can6.   

Abstract

We described the predictive role of cytokines in fatality of Crimean Congo Hemorrhagic Fever Virus (CCHFV) infection by using daily clinical sera samples. Consequent serum samples of the selected patients in different severity groups and healthy controls were examined by using human cytokine 17-plex assay. We included 12 (23%) mild, 30 (58%) moderate, 10 (19%) severe patients, and 10 healthy volunteers. The mean age of the patients was 52 (sd 15), 52% were female. Forty-six patients (88%) received ribavirin. During disease course, the median levels of IL-6, IL-8, IL-10, IL-10/12, IFN-γ, MCP-1, and MIP-1b were found to be significantly higher among CCHF patients than the healthy controls. Within the first 5 days after onset of disease, among the fatal cases, the median levels of IL-6 and IL-8 were found to be significantly higher than the survived ones (Fig. 3), and MCP-1 was elevated among fatal cases, but statistical significance was not detected. In receiver operating characteristic (ROC) analysis, IL-8 (92%), IL-6 (92%), MCP-1 (79%) were found to be the most significant cytokines in predicting the fatality rates in the early period of the disease (5 days). IL-6 and IL-8 can predict the poor outcome, within the first 5 days of disease course. Elevated IL-6 and IL-8 levels within first 5 days could be used as prognostic markers.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  crimean-congo hemorrhagic fever; cytokine; ribavirin

Mesh:

Substances:

Year:  2017        PMID: 28547808     DOI: 10.1002/jmv.24864

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

Review 1.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

2.  A cynomolgus macaque model for Crimean-Congo haemorrhagic fever.

Authors:  Elaine Haddock; Friederike Feldmann; David W Hawman; Marko Zivcec; Patrick W Hanley; Greg Saturday; Dana P Scott; Tina Thomas; Miša Korva; Tatjana Avšič-Županc; David Safronetz; Heinz Feldmann
Journal:  Nat Microbiol       Date:  2018-04-09       Impact factor: 17.745

Review 3.  Ribavirin for treating Crimean Congo haemorrhagic fever.

Authors:  Samuel Johnson; Nicholas Henschke; Nicola Maayan; Inga Mills; Brian S Buckley; Artemisia Kakourou; Rachel Marshall
Journal:  Cochrane Database Syst Rev       Date:  2018-06-05

4.  Characterization of Biomarker Levels in Crimean-Congo Hemorrhagic Fever and Hantavirus Fever with Renal Syndrome.

Authors:  Miša Korva; Katarina Resman Rus; Miša Pavletič; Ana Saksida; Nataša Knap; Mateja Jelovšek; Katja Strašek Smrdel; Xhevat Jakupi; Isme Humolli; Jusuf Dedushaj; Miroslav Petrovec; Tatjana Avšič-Županc
Journal:  Viruses       Date:  2019-07-26       Impact factor: 5.048

Review 5.  Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.

Authors:  Aura R Garrison; Darci R Smith; Joseph W Golden
Journal:  Viruses       Date:  2019-06-28       Impact factor: 5.048

6.  Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis.

Authors:  Darci R Smith; Charles J Shoemaker; Xiankun Zeng; Aura R Garrison; Joseph W Golden; Christopher W Schellhase; William Pratt; Franco Rossi; Collin J Fitzpatrick; Joshua Shamblin; Adrienne Kimmel; Justine Zelko; Olivier Flusin; Jeffrey W Koehler; Jun Liu; Kayla M Coffin; Keersten M Ricks; Matt A Voorhees; Randal J Schoepp; Connie S Schmaljohn
Journal:  PLoS Pathog       Date:  2019-09-26       Impact factor: 6.823

7.  Dual RNA-Seq characterization of host and pathogen gene expression in liver cells infected with Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Robert A Kozak; Russell S Fraser; Mia J Biondi; Anna Majer; Sarah J Medina; Bryan D Griffin; Darwyn Kobasa; Patrick J Stapleton; Chantel Urfano; Giorgi Babuadze; Kym Antonation; Lisa Fernando; Stephanie Booth; Brandon N Lillie; Gary P Kobinger
Journal:  PLoS Negl Trop Dis       Date:  2020-04-06

Review 8.  Crimean-Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures.

Authors:  E J Mendoza; B Warner; D Safronetz; C Ranadheera
Journal:  Zoonoses Public Health       Date:  2018-04-20       Impact factor: 2.702

9.  Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis.

Authors:  Charlene Ranadheera; Emelissa J Valcourt; Bryce M Warner; Guillaume Poliquin; Kyle Rosenke; Kathy Frost; Kevin Tierney; Greg Saturday; Jinxin Miao; Jonna B Westover; Brian B Gowen; Stephanie Booth; Heinz Feldmann; Zhongde Wang; David Safronetz
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.996

10.  Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice.

Authors:  Stephen R Welch; Jana M Ritter; Anita K McElroy; Jessica R Harmon; JoAnn D Coleman-McCray; Florine E M Scholte; Gary P Kobinger; Éric Bergeron; Sherif R Zaki; Stuart T Nichol; Jessica R Spengler; Christina F Spiropoulou
Journal:  PLoS Pathog       Date:  2019-12-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.